Markers and meaning of primary treatment failure
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 30 (2) , 377-401
- https://doi.org/10.1016/s0094-0143(02)00176-3
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- IS ANASTOMOTIC BIOPSY NECESSARY BEFORE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY?Journal of Urology, 2001
- DEFINING PROSTATE SPECIFIC ANTIGEN PROGRESSION AFTER RADICAL PROSTATECTOMY: WHAT IS THE MOST APPROPRIATE CUT POINT?Journal of Urology, 2001
- LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARSJournal of Urology, 2000
- PATHOLOGICAL FEATURES AND PROGNOSTIC SIGNIFICANCE OF PROSTATE CANCER IN THE APICAL SECTION DETERMINED BY WHOLE MOUNT HISTOLOGYJournal of Urology, 1999
- ( 111 ) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMYJournal of Urology, 1998
- Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigenWorld Journal of Urology, 1997
- A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate CancerJournal of Urology, 1995
- Assay variability in serum prostate‐specific antigen determinationThe Prostate, 1995
- Original Articles: Prostate Cancer: Variable Histology of Anastomotic Biopsies With Detectable Prostate Specific Antigen After Radical ProstatectomyJournal of Urology, 1995
- The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancerCancer, 1993